Related Experiment Video

Updated: Jun 3, 2026

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay
11:14

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Published on: November 10, 2013

Copper, gold and silver compounds as potential new anti-tumor metallodrugs

Shiow Jin Tan1, Yaw Kai Yan, Peter Peng Foo Lee

  • 1Division of Chemical & Biomolecular Engineering, School of Chemical & Biomedical Engineering, Nanyang Technological University, Singapore 637616.

Future Medicinal Chemistry
|March 24, 2011
PubMed

Insights

New anticancer drugs using copper, gold, and silver show promise. These coinage metal complexes offer improved efficacy and lower toxicity compared to traditional platinum-based chemotherapy agents.

Area of Science:

  • Medicinal Chemistry
  • Inorganic Chemistry
  • Pharmacology

Background:

  • Platinum-based chemotherapy, while effective, presents significant limitations including toxicity and narrow anti-cancer spectrum.
  • The need for novel anticancer agents with improved efficacy and reduced side effects is critical in oncology.
  • Coinage metals (copper, gold, silver) are emerging as promising platforms for developing new anti-tumor drugs.

Purpose of the Study:

  • To review recent advancements in the design of coinage metal complexes as anticancer agents.
  • To discuss the role of quantitative structure-activity relationship (QSAR) methods in optimizing these metal-based drugs.
  • To propose future research directions in the field of anti-tumor coinage metal complexes.

Main Methods:

  • Literature review of recent studies on coinage metal complexes with anti-tumor activity.
  • Analysis of structure-activity relationships for optimizing bioactivity.
  • Exploration of QSAR methodologies applied to anticancer metal complexes.

Main Results:

  • Coinage metal complexes demonstrate significant potential as anticancer agents.
  • Structural modifications can enhance the anti-tumor efficacy and reduce toxicity of these complexes.
  • QSAR methods are increasingly important for rational drug design in this area.

Conclusions:

  • Coinage metal complexes represent a promising alternative to platinum-based drugs.
  • Further research focusing on QSAR and structural optimization is crucial for developing effective metal-based cancer therapies.
  • Future investigations are expected to identify novel and potent coinage metal anticancer agents.

More Related Videos

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents07:20

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...